ResearcherUniversity of Southern CaliforniaNo recent work listed

Amy Shiu Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0378-5443; OpenAlex author ID A5100686480; NIH RePORTER profile ID 1901968. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 6

Papers, trials and grants by year

2015: 1 grant · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 2

Grants 1

Targeting Cell Surface GRP78 as a Novel Therapy for Pancreatic Cancer R21CA179273 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dat P. Ha · 1 shared paper, 2021 · strength 0.22
- Paper Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pa… DOI 10.1016/j.neo.2021.10.004 ↗
Mats E. Ljungman · 1 shared paper, 2021 · strength 0.13
- Paper The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-20-1540 ↗
Soma Samanta · 1 shared paper, 2021 · strength 0.13
- Paper The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-20-1540 ↗
Ding Xue · 1 shared paper, 2021 · strength 0.13
- Paper The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-20-1540 ↗
Nouri Neamati · 1 shared paper, 2021 · strength 0.13
- Paper The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-20-1540 ↗
Yuting Kuang · 1 shared paper, 2021 · strength 0.13
- Paper The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. DOI 10.1158/0008-5472.can-20-1540 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.